Top Tech Jobs & Startup Jobs

As a pharmacometrician at Pfizer, you will conduct quantitative analyses related to drug development, focusing on pharmacokinetics, pharmacodynamics, and disease modeling. You will collaborate with multidisciplinary teams to support drug efficacy, safety, and commercial viability assessments through presentations and regulatory documentation. You will also contribute to improving methodologies and mentor less experienced colleagues.

The Director, HTA, Value & Evidence (HV&E) for Breast Cancer at Pfizer drives optimal patient access for breast cancer medicines by developing evidence generation strategies, leading HEOR studies, and ensuring alignment of clinical trials with reimbursement needs. This role involves collaboration with cross-functional teams and external stakeholders to support product launch and lifecycle needs.

The Director, HTA, Value & Evidence will lead evidence generation strategies for Pfizer's breast cancer portfolio, focusing on Atirmociclib. Responsibilities include coordinating HEOR studies, developing launch deliverables, and ensuring regulatory compliance to support patient access and reimbursement. This role involves collaboration across teams and strategic partnerships to promote innovative healthcare solutions.

The Director, HTA, Value & Evidence will develop and execute global evidence generation strategies to promote patient access to breast cancer medicines, particularly Atirmociclib. Responsibilities include coordinating HEOR studies, developing launch deliverables, and ensuring that the evidence strategy aligns with market access needs while fostering innovation in collaboration with global teams.

The Director, HTA, Value & Evidence - Breast Cancer will lead evidence generation strategies for breast cancer medicines, particularly Atirmociclib, to ensure optimal patient access. Responsibilities include coordinating with internal teams, designing HEOR studies, overseeing launch deliverables, and developing partnerships with external stakeholders to support reimbursement and access requirements.

The Director will drive optimal patient access for breast cancer medicines, focusing on developing and executing global evidence generation strategies. Responsibilities include leading HEOR studies, developing value evidence strategies, and strategic partnerships with stakeholders to support market access initiatives.

The Director of HTA, Value & Evidence for Breast Cancer will lead the evidence generation strategy for Atirmociclib, managing HEOR activities to support global patient access and reimbursement strategies. Responsibilities include coordinating input on evidence needs, executing global HEOR studies, developing launch deliverables, and creating partnerships with external experts and stakeholders.